Healthmonix announces 2026 MIPSpro Enterprise QCDR, expanding support for key healthcare specialties
Malvern, Pa. (Feb. 2, 2026) — Healthmonix today announced the release of its 2026 MIPSpro Enterprise Qualified Clinical Data Registry (QCDR), approved by the Centers for Medicare and Medicaid Services (CMS) for the 2026 performance year. The QCDR is offered as part of Healthmonix’s broader designation as a 2026 CMS Qualified Registry, supporting quality measurement, performance calculation, and submission across MIPS, MVPs, MSSP, and other value-based care programs.
The 2026 MIPSpro Enterprise QCDR supports specialty-specific quality measurement across musculoskeletal care, radiology, cardiology, and vestibular rehabilitation. It enables providers to report on clinically meaningful measures that better reflect the care they deliver while meeting CMS reporting requirements.
Healthmonix maintains a QCDR to ensure providers have access to outcome-focused, specialty-relevant measures in areas where standard MIPS measures may not fully capture performance. Through the MIPSpro Enterprise QCDR, Healthmonix works with clinical experts to develop, refine, and maintain measures that align regulatory reporting with real-world clinical practice.
“Quality reporting in 2026 is no longer about checking boxes. It’s about giving providers the clarity and flexibility they need to succeed across multiple programs at once,” said Lauren Patrick, CEO of Healthmonix. “The 2026 MIPSpro Enterprise QCDR reflects how our customers actually practice medicine today.
“As part of the evolved Prism™ platform, it supports specialty-specific, outcomes-driven measurement and adapts seamlessly to traditional MIPS, MVPs, MSSP, ASM, and other value-based care models. Built-in logic helps providers stay compliant while optimizing performance.”
As a CMS Qualified Registry for 2026, Healthmonix supports providers with end-to-end performance calculation, measure selection guidance, and submission services. The MIPSpro Enterprise QCDR complements this offering by expanding the set of available quality measures and enabling more precise alignment between clinical care and performance reporting.
Providers using the MIPSpro Enterprise QCDR also benefit from Healthmonix Cost, the company’s cost analytics solution that delivers transparency into Cost category performance using each organization’s actual Medicare billing data.
Specialties supported by the 2026 MIPSpro Enterprise QCDR
The 2026 MIPSpro Enterprise QCDR supports quality measurement across the following clinical areas:
Musculoskeletal care
MIPSpro Enterprise includes functional status and pain improvement measures for patients treated for neck, upper extremity, back, lower extremity, and knee conditions. These measures support outcomes-driven rehabilitation and patient-centered care for therapy and rehabilitation providers.
Radiology
MIPSpro Enterprise offers measures focused on diagnostic accuracy and standardized reporting, including comprehensive reporting of coronary artery calcification on chest CT and interpretation of CT pulmonary angiography for pulmonary embolism.
Cardiology
MIPSpro Enterprise contains imaging-based measures that support early identification of cardiovascular risk, including coronary artery calcification reporting on chest CT.
Vestibular and balance care
MIPSpro Enterprise features outcome-based measurement for patients treated for vestibular disorders, supporting meaningful demonstration of functional improvement.
The QCDR structure also enables Healthmonix to respond efficiently to evolving CMS requirements. As MIPS, MVPs, and alternative payment models continue to change, the registry allows Healthmonix to update measures, scoring logic, and reporting workflows while reducing provider burden.
Through its registries, analytics, and data integration capabilities, Healthmonix has partnered with provider organizations nationwide to deliver measurable improvements in quality and cost performance, supporting more than $800 million in realized savings during the 2024 performance year.
About Healthmonix
Healthmonix is a leader in healthcare analytics and performance improvement, delivering end-to-end solutions that simplify regulatory reporting and empower healthcare organizations to succeed in value-based care. With a focus on quality, cost, and actionable insight, Healthmonix partners with providers nationwide to improve outcomes, enhance efficiency, and drive measurable value across the healthcare continuum.